A heated constitutional and political battle is unfolding in Senegal as lawmakers examine whether Ousmane Sonko can reclaim his parliamentary seat after leaving government. The debate could reshape the balance of power inside the National Assembly.
An Ebola outbreak has spread accross the DRC and Uganda (Picture: AFP via Getty Images)
A 28-year-old woman who travelled to the Indian city of Bengaluru from Uganda has been placed in quarantine wit
SINGAPORE,Jan. 13,2025-- Sodion Energy,a leading provider of sodium-ion batteries for e-mobility and integrated energy storage solutions in Southeast Asia,has secured a landmark agreement for an init
LAS VEGAS,Jan. 11,2025-- Think Academy debuted its Thinkpal tablet at CES 2025 and has won a TechRadar Pro Picks and Trusted Reviews Best in Show awards for this innovative new product.
HONG KONG,Jan. 11,2025-- Dunxin Financial Holdings("DXF" or the "Company") (OTC Pink: DXFFY,DXFFD)is pleased to announce that effective on January10,2025,the Company will change it
SHANGHAI,Jan. 11,2025-- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American:BQ) today announced that it will change its ratio of its American Depositary Shares ("A
LAS VEGAS,Jan. 11,2025--At CES 2025,Khadas captivated global audiences with groundbreaking product designs and innovative technologies,showcasing the immense potential of next-generation computing dev
SINGAPORE,Jan. 13,2025-- Skyee Pte. Ltd. ("Skyee") is excited to announce that it has been granted In-Principle Approval (IPA) for the Major Payment Institution (MPI) license from the Moneta
HANGZHOU,China,Jan. 10,2025-- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"),a leading integrated smart supply chain solutions and logistics services provider in China and Southe
CHANGZHOU,China,Jan. 10,2025-- Recently,Trina Storage has once again secured a top spot in BloombergNEF\'s (BNEF) Energy Storage System Cost Survey 2024,acknowledged for its cutting-edge products,tec
SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a